Vision Care, Sri Lanka’s largest vision, hearing, and eyewear solutions, provider, made a significant impact at the 14th ...

Cortisol the hormone released due to stress might be a potential factor in increasing the risk of glaucoma Learn how higher ...

The novel nitric oxide-donating bimatoprost eye drop is being clinically developed for the lowering of IOP in patients with ...

Learn to spot early warning signs from your eyes that may signal serious health issues and protect your vision before it's ...

The 9 recipients receive $55,000 in seed money for collaborative projects that target one or more of the foundation’s ...

To mark World Optometry Day (23 March 2025), a community healthcare provider in Yorkshire is encouraging eyecare patients to ...

Hopkins engineer Vicky Nguyen has spent 15 years studying how glaucoma progresses to figure out how to preserve patients' ...

A combination of low blood pressure and high intraocular pressure can predict RNFL thinning in moderate-to-severe glaucoma.

Combination, if successful, would create a new publicly-listed eye care company combining Betaliq’s EyeSol® water-free drug delivery technology ...

Eyenovia (EYEN), has entered into a non-binding letter of intent contemplating a potential reverse merger transaction with Betaliq, a clinical ...

A recent study has raised concerns about a widely used blood pressure medication called Calcium Channel Blockers (CCBs).

Glucagon-like peptide 1 receptor agonists appear to reduce the risk of age-related macular degeneration and primary open-angle glaucoma.